• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

A New treatment strategy using analysis of anti-transcriptional factors antibody in connective tissue diseases.

Research Project

Project/Area Number 20591179
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 膠原病・アレルギー・感染症内科学
Research InstitutionUniversity of Occupational and Environmental Health, Japan

Principal Investigator

SAITO Kazuyoshi  University of Occupational and Environmental Health, Japan, 医学部, 准教授 (30279327)

Co-Investigator(Kenkyū-buntansha) KOHNO Kimitoshi  産業医科大学, 医学部, 教授 (00153479)
Co-Investigator(Renkei-kenkyūsha) TANAKA Yoshiya  産業医科大学, 医学部, 教授 (30248562)
Project Period (FY) 2008 – 2010
Project Status Completed (Fiscal Year 2010)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywords膠原病学 / 抗転写因子抗体 / 膠原病 / 転写因子 / 自己抗体
Research Abstract

We developed a new detection system for anti-body against transcriptional factors in connective tissue diseases. Ninety six nuclear factors that involved in cell cycle and homeostasis were blotted on the DEAE paper and incubated with serum from the patients with connective tissue diseases including SLE, dermatomyositis, polyangitis. Anti-HMG1 antibody was detected in 2 patients with polyangitis. Antibody against PCNA was observed in 2 SLE but the serum reacted with a lot of nuclear factors irrelevant with organ specificity. Acetylation and methylation of nuclear factors did not affect on the result of detection of auto-antibody.

Report

(4 results)
  • 2010 Annual Research Report   Final Research Report ( PDF )
  • 2009 Annual Research Report
  • 2008 Annual Research Report
  • Research Products

    (13 results)

All 2011 2010 2009

All Journal Article (11 results) (of which Peer Reviewed: 11 results) Presentation (2 results)

  • [Journal Article] Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus who are in the long-term remission After B Cell Depletion Therapy with Rituximab2011

    • Author(s)
      Iwata S, Saito K, Tokunaga M, Yamaoka K, Nawata M, Yukawa S, Hanami K, Fukuyo S, Kubo S, Miyagawa I, Tanaka Y
    • Journal Title

      Journal of Rheumatology 38(4)

      Pages: 633-41

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behcet's disease.2011

    • Author(s)
      Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Hanami K, Tanaka Y
    • Journal Title

      Mod Rheumatol. 21(2)

      Pages: 184-91

    • NAID

      10029361883

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus who are in the long-term remission After B Cell Depletion Therapy with Rituximab2011

    • Author(s)
      Iwata S, Saito K, et al.
    • Journal Title

      Journal of Rheumatology

      Volume: in press

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Efficacy of combination therapy of anti-TNF-a antibody infliximab and methotrexate in refractory entero-Behcet's disease2011

    • Author(s)
      Iwata S, Saito K, et al.
    • Journal Title

      Mod Rheumatol

      Volume: in press

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis.2010

    • Author(s)
      Tsujimura S, Saito K, Nakayamada S, Tanaka Y
    • Journal Title

      Modern Rheumatology 20(2)

      Pages: 139-146

    • NAID

      10027168842

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis.2010

    • Author(s)
      Suzuki K, Saito K, Tsujimura S, Nakayamada S, Yamaoka K, Sawamukai N, Iwata S, Nawata M, Nakano K, Tanaka Y
    • Journal Title

      J Rheumatol. 37(3)

      Pages: 512-520

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Y-box binding protein-1 is a novel molecular target for tumor vessels.2010

    • Author(s)
      Takahashi M, Shimajiri S, Izumi H, Hirano G, Kashiwagi E, Yasuniwa Y, Ying W, Han B, Akiyama M, Nishizawa S, Sasaguri Y, Kohno K
    • Journal Title

      Cancer Sci. 101

      Pages: 1367-1373

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis2010

    • Author(s)
      Tsujimura S, Saito K,, et al.
    • Journal Title

      Modern Rheumatology (in press)

    • NAID

      10027168842

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness me diated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis2010

    • Author(s)
      Suzuki K, Saito K, et al.
    • Journal Title

      J Rheumatol. 37(3)

      Pages: 512-520

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.2009

    • Author(s)
      Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, Tanaka Y
    • Journal Title

      Rheumatology 48(8)

      Pages: 1012-1013

    • Related Report
      2010 Final Research Report
    • Peer Reviewed
  • [Journal Article] Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.2009

    • Author(s)
      Iwata S, Saito K, et al.
    • Journal Title

      Rheumatology 48(8)

      Pages: 1012-1013

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Presentation] Humanized anti human Interlukin-6 receptor monoclonal antibody tocilizumab (TCZ) increases high molecular weight adiponectin (HMW-AN) in the patients with rheumatoid arthritis (RA) : result from The ESCORT study2010

    • Author(s)
      Saito K, Hanami k, Nawata M, Yunoue N, Tanaka Y
    • Organizer
      The 11th Annual European Congress of Rheumatology (EULAR)
    • Place of Presentation
      Roma(Fiera Rome)
    • Year and Date
      2010-06-16
    • Related Report
      2010 Final Research Report
  • [Presentation] Humanized anti-human Intedukin-6 receptor monoclonal antibody tocilizumab(TCZ)increases high molecules weight adiponectin(HMW-AN)in the patients with rheumatoid arthritis(RA): result from The ESCORT study2010

    • Author(s)
      Saito K
    • Organizer
      The 11th Annual European Congress of Rheu matology(EULAR)
    • Place of Presentation
      Roma(Fiera Rome)
    • Year and Date
      2010-06-16
    • Related Report
      2010 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi